Adrafinil

CAT:
804-HY-17549-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Adrafinil - image 1

Adrafinil

  • Description:

    Adrafinil (CRL-40028, Olmifon), prodrug of modafinil, is a mild central nervous system stimulant drug used to relieve excessive sleepiness and inattention, Adrafinil is believed to serve as an alpha-1 adrenoceptor agonist. IC50 value: Target: in vitro: in vivo: CRL 40028 antagonizes prazosin-induced hypothermia and hypomotility; prazosin antagonizes the anticonvulsant effect of CRL 40028 in the quaking mouse [1]. Adrafinil in rat serum was stable over three freeze-thaw cycles at ambient temperature for 6 h. The method had a lower limit of quantitation of 16.5 ng/ml, which offered high sensitivity for the determination of adrafinil in serum [2]. Aged beagle dogs were trained on either a size or intensity discrimination task 2 h following treatment with either 20 mg/kg of adrafinil or a placebo control. Treatment with adrafinil produced significant improvement in learning, as indicated by a decrease in both errors and trials to criterion. An effect of adrafinil on motivation may partially account for these findings; however, adrafinil did not significantly affect response latency. Adrafinil is believed to serve as an alpha-1 adrenoceptor agonist [3].
  • Product Name Alternative:

    CRL 40028
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302
  • Target:

    Adrenergic Receptor
  • Type:

    Reference compound
  • Related Pathways:

    GPCR/G Protein; Neuronal Signaling
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease; Endocrinology
  • Assay Protocol:

    https://www.medchemexpress.com/adrafinil.html
  • Purity:

    99.85
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C (NO) CS (C (C1=CC=CC=C1) C2=CC=CC=C2) =O
  • Molecular Formula:

    C15H15NO3S
  • Molecular Weight:

    289.35
  • Precautions:

    H302
  • References & Citations:

    [1]Simon P, et al. Pharmacological evidence of the stimulation of central alpha-adrenergic receptors. Prog Neuropsychopharmacol Biol Psychiatry. 1983;7 (2-3) :183-6.|[2]Rao RN, et al. LC-ESI-MS determination and pharmacokinetics of adrafinil in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873 (1) :119-23.|[3]Milgram NW, et al. Oral administration of adrafinil improves discrimination learning in aged beagle dogs. Pharmacol Biochem Behav. 2000 Jun;66 (2) :301-5.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Launched
  • CAS Number:

    63547-13-7